Fig. 2From: Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection preventionRisk concerns and perceptions among the 449 women taking HIV PrEP and enrolled in the dPEP TrialBack to article page